AI-Based Skin Cancer Examination Software

About Speclipse

Speclipse is a private, commercial-stage company positioned at the intersection of medical aesthetics and dermatological diagnostics. It has built a proprietary technology platform integrating pulsed laser hardware, laser-induced breakdown spectroscopy (LIBS), and deep learning algorithms to enable real-time, non-invasive skin cancer triage. The company holds numerous international certifications and patents, has commercial products in the aesthetic laser market, and is advancing its AI-powered diagnostic device, Spectra-Scope, through clinical validation and regulatory pathways. Its strategy leverages core laser engineering expertise to address two high-growth adjacent markets: cosmetic procedures and early cancer detection.

Therapeutic Areas